Semaglutide Biosimilar(iX Biopharma)

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug NameSemaglutide Biosimilar(iX Biopharma)
Drug Alias NameSemaglutide Sublingual WaferiXB-401
ClassificationBiologics > Biosimilar
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIx Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIx Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A